Ignite Creation Date:
2024-05-06 @ 1:23 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01793649
Status:
TERMINATED
Last Update Posted:
2014-03-20
First Post:
2013-02-14
Brief Title:
A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance MCC in Healthy Subjects
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Study Overview
Official Title:
A Phase 1 Randomized Double-Blind Cross-Over Vehicle-Controlled Single-Dose Study To Characterize The Effect of GS-5737 Enhancement of Mucociliary Clearance MCC In Healthy Subjects
Status:
TERMINATED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind cross-over vehicle-controlled study to determine whether GS-5737 in 28 saline accelerates mucociliary clearance MCC in healthy subjects compared to vehicle of 28 saline alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None